General Psychiatry
General Psychiatry RSS Feed RSS

Psychotherapy and Medication in Recurrent Depression

June 29, 2021
Giovanni Fava, MD
Giovanni Fava, MDGiovanni Fava, MD

Clinical Professor of Psychiatry at the State University of New York at Buffalo. Editor-in-Chief of the journal Psychotherapy and Psychosomatics and author of over 500 scientific papers. His book, Discontinuing Antidepressant Medications, is due from Oxford University Press in 2021. Dr. Fava has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Antidepressants treat depression, but patients need something more to prevent future episodes. Giovanni Fava describes an evidence-based method that blends medication with psychotherapy in two phases: sequential treatment for prevention of depression.
Read More

How to Write an Open Note

June 29, 2021
Tony Thrasher, DO, DFAPA.
Tony Thrasher, DO, DFAPA. President, American Association for Emergency Psychiatry (AAEP). Medical Director of Crisis Services, Milwaukee County Behavioral Health, Milwaukee, WI. Clinical Associate Professor, Medical College of Wisconsin, Milwaukee, WI. Dr. Thrasher has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Medical notes may never be the same again. The Open Notes policy allows patients to read their record without delay, and nearly prevents doctors from withholding notes in the interest of safety. Here we share tips on how to use this policy to enhance the therapeutic relationship.
Read More

Genetic Testing: What You Need to Know in 2021

June 29, 2021
John Nurnberger, MD, PhD
John Nurnberger, MD, PhDJohn Nurnberger, MD, PhD

Vice Chair for Preclinical Research, Department of Psychiatry, Indiana University, Indianapolis, IN. Dr. Nurnberger has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Is genetic testing ready for clinical practice? It depends on which test we’re talking about. In this interview John Nurnberger details the tests to pay attention to on a genetic panel and describes how to use whole exome sequencing (WES) to identify genetic causes of autism and intellectual disability.
Read More

Two Negative Studies of Mirtazapine and Riluzole for PTSD in Veterans

June 29, 2021
Richard Moldawsky, MD.
Richard Moldawsky, MD. Dr. Moldawsky has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Medications don’t have a good track record in PTSD, particularly in combat related trauma. Here we review two controlled trials where an old standby (mirtazapine) and a hopeful contender (riluzole) come up short.
Read More

In Brief: Lamotrigine Gets a New Warning

May 4, 2021
Chris Aiken, MD, and Sarah Rivelli, MD.
Chris Aiken, MD, and Sarah Rivelli, MD. Dr. Aiken and Dr. Rivelli have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
A new warning now sits beneath the list of life-threatening allergic reactions that can happen with lamotrigine. The anticonvulsant is suspected of causing cardiac arrhythmias in susceptible patients by slowing ventricular conduction and widening the QRS.
Read More

A Review of Medications for PTSD, With a Focus on Topiramate

May 4, 2021
Paul Riordan, MD.
Paul Riordan, MD. Assistant Consulting Professor of Psychiatry, Duke University. Dr. Riordan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Topiramate is not first-line in PTSD, but it does have a role, particularly when alcohol use is part of the picture.
Read More

What’s Wrong With Generics?

May 4, 2021
Katherine Eban
Katherine EbanKatherine Eban

Katherine Eban is an investigative journalist whose 2019 book Bottle of Lies: The Inside Story of the Generic Drug Boom uncovered problems in generic drug manufacturing. Ms. Eban has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Generic recalls are on the rise: Bupropion, methylphenidate, and metformin, to name a few. Katherine Eban explains the limits of FDA oversight, and what we can do to protect our patients when quality control cones under suspicion.
Read More
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
Featured Video
Featured Podcast
Recommended

About

Shop Online

Newsletters

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.